Calcium and Beta Receptor Antagonist Overdose: A Review and Update of Pharmacological Principles and Management

 

 Buy Article Permissions and Reprints

ABSTRACT

Calcium channel and beta-adrenergic receptor antagonists are common pharmaceutical agents with multiple overlapping clinical indications. When used appropriately, these agents are safe and efficacious. In overdose, however, these agents have the potential for serious morbidity. Calcium channel blockers and beta blockers share similar physiological effects on the cardiovascular system, such as hypotension and bradycardia, in overdose and occasionally at therapeutic doses. The initial management for symptomatic overdose of both drug classes consists of supportive care measures. Other therapies including administration of glucagon, calcium, catecholamines, phosphodiesterase inhibitors and insulin have been used with varying degrees of success. In addition, intra-aortic balloon pump and extracorporeal membrane oxygenation techniques have been successfully utilized in refractory cases. This article reviews beta blocker and calcium channel blocker pharmacological principles and updates current management strategies.

REFERENCES

• 1 The United States Pharmacopeial Convention. USPDI: Approved Drug Products and Legal Requirements. 20th ed. Taunton, Mass.: World Color Book Services; 2000
• 2 Litovitz T L, Klein-Schwartz W, White S. 1999 Annual Report of the American Poison Control Centers Toxic Exposure Surveillance System.  Am J Emerg Med . 2000;  18 517-574
  CrossrefPubMedGoogle Scholar
• 3 Adams R J, Schwartz A. Comparative mechanisms for contraction of cardiac and skeletal muscle.  Chest . 1980;  78 123-137
  PubMedGoogle Scholar
• 4 Hartshorne D J. Biochemical basis for contraction of vascular smooth muscle.  Chest . 1980;  78 140-149
  PubMedGoogle Scholar
• 5 Abernethy D R, Schwartz J B. Calcium-antagonist drugs.  N Engl J Med . 1999;  341 1447-1457
  CrossrefPubMedGoogle Scholar
• 6 Levitski A, Marbach I, Bar-Sinai A. The signal transduction between beta receptors and adenyl cyclase.  Life Sci . 1993;  52 2093-2100
  CrossrefPubMedGoogle Scholar
• 7 DeRoos F. Calcium channel blockers. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies 6th ed. Stamford, Conn.: Appleton & Lange 1998: 829-843
  Google Scholar
• 8 Buckley C D, Aronson J K. Prolonged half-life of verapamil in a case of overdose: implications for therapy.  Br J Clin Pharmacol . 1995;  39 680-683
  PubMedGoogle Scholar
• 9 Adams B D, Browne W T. Amlodipine overdose causes prolonged calcium channel blocker toxicity.  Am J Emerg Med . 1998;  16 527-528
  CrossrefPubMedGoogle Scholar
• 10 Ramoska E A, Spiller H A, Winter M. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment.  Ann Emerg Med . 1993;  22 196-200
  PubMedGoogle Scholar
• 11 Love J N. Beta-blocker toxicity after overdose: when do symptoms develop in adults?.  J Emerg Med . 1994;  12 799-802
  CrossrefPubMedGoogle Scholar
• 12 Brubracher J R. Beta-adrenergic antagonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's Toxicologic Emergencies 6th ed. Stamford, Conn.: Appleton & Lange 1998: 809-825
  Google Scholar
• 13 Wiest D. Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics.  Clin Pharm . 1995;  28 190-202
  PubMedGoogle Scholar
• 14 Henry J A, Cassidy S L. Membrane stabilizing activity: a major cause of fatal poisoning.  Lancet . 1986;  8495 1414-1417
  PubMedGoogle Scholar
• 15 Pritchard B N, Battersby L A, Cruikshank J M. Overdosage with beta adrenergic blocking agents.  Adv Drug React Poison Rev . 1984;  3 91-111
  PubMedGoogle Scholar
• 16 Reith D M, Dawson A H, Epid D. Relative toxicity of beta blockers in overdose.  Clin Toxicol . 1996;  34 273-278
  PubMedGoogle Scholar
• 17 Buiumsohn A, Eisenberg E S, Jacob H. Seizures and intraventricular conduction defect in propanolol poisoning: a report of two cases.  Ann Int Med . 1979;  91 860-862
  PubMedGoogle Scholar
• 18 Frishman W, Jacob H, Eisenberg E, Ribner H. Clinical pharmacology of the new beta-adrenergic blocking drugs, VIII: Self-poisoning with beta-adrenergic blocking agents: recognition and Management.  Am Heart J . 1979;  98 798-811
  CrossrefPubMedGoogle Scholar
• 19 Hohnloser S H, Woolsey R L. Sotalol.  N Engl J Med . 1994;  331 31-38
  CrossrefPubMedGoogle Scholar
• 20 Krapf R, Gertsch M. Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.  Br Med J . 1985;  290 1784-1785
  PubMedGoogle Scholar
• 21 Proano L, Chiang W K, Wang R Y. Calcium channel blocker overdose.  Am J Emerg Med . 1995;  13 444-450
  CrossrefPubMedGoogle Scholar
• 22 Ramoska E A, Spiller H A, Myers A. Calcium channel blocker toxicity.  Ann Emerg Med . 1990;  19 649-653
  PubMedGoogle Scholar
• 23 Lundborg P. The effect of adrenergic blockade on potassium concentrations in different conditions.  Acta Med Scand . 1983;  672 121-126
  PubMedGoogle Scholar
• 24 Wax P. Intestinal infarction due to nifedipine overdose.  J Toxicol Clin Toxicol . 1995;  33 725-728
  PubMedGoogle Scholar
• 25 Samniah N, Schlaeffer F. Cerebral infarction associated with oral verapamil overdose.  J Toxicol Clin Toxicol . 1988;  26 365-369
  PubMedGoogle Scholar
• 26 Devis G, Somers G, Van Obberghen E. Calcium antagonists and islet function: inhibition of insulin release by verapamil.  Diabetes . 1975;  24 547-551
  PubMedGoogle Scholar
• 27 Brass B J, Winchester-Penny S, Lipper B L. Massive verapamil overdose complicated by noncardiogenic pulmonary edema.  Am J Emerg Med . 1996;  14 459-461
  CrossrefPubMedGoogle Scholar
• 28 Pettei M J, Levy J, Abramson S. Nonocclusive mesenteric ischemia associated with propanolol overdose: implications regarding splanchnic circulation.  J Pediatr Gastroenterol and Nutr . 1990;  10 544-547
  PubMedGoogle Scholar
• 29 Rooney M, Massey K L, Jamali F. Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation.  J Clin Pharmacol . 1996;  36 760-763
  PubMedGoogle Scholar
• 30 Schofield P M, Beath S V, Mant T K. Recovery after severe oxprenolol overdose complicated by rhabdomyolysis.  Human Toxicol . 1985;  4 57-60
  PubMedGoogle Scholar
• 31 Thomson D F, Skaehill P A. Drug induced lichen planus.  Pharmacother . 1994;  14 561-571
  PubMedGoogle Scholar
• 32 Anonymous. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care, VI: Advanced cardiovascular life support, VIIA: Principles and practice of ACLS. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation.  Circulation . 2000;  102 I136-139
  PubMedGoogle Scholar
• 33 Taboulet P, Cariou A, Berdeaux A. Pathophysiology and management of self-poisoning with beta-blockers.  Clin Toxicol . 1993;  31 531-551
  PubMedGoogle Scholar
• 34 Lane A S, Woodward A C, Goldman M R. Massive propanolol overdose poorly responsive to pharmacologic therapy: use of the intra-aortic balloon pump.  Ann Emerg Med . 1987;  16 1381-1383
  PubMedGoogle Scholar
• 35 Haltori V T, Mandel W J, Pete T. Calcium for myocardial depression from verapamil.  N Engl J Med . 1982;  306 238
  PubMedGoogle Scholar
• 36 Lipman J, Jardine I, Roos C. Intravenous calcium chloride as an antidote to verapamil-induced hypotension.  Intensive Care Med . 1982;  8 55-57
  CrossrefPubMedGoogle Scholar
• 37 Love J N, Hanfling D, Howell J M. Hemodynamic effects of calcium chloride in a canine model of acute propanolol intoxication.  Ann Emerg Med . 1996;  28 1-6
  CrossrefPubMedGoogle Scholar
• 38 Crump B J, Holt D W, Vale J A. Lack of response to intravenous calcium in severe verapamil poisoning.  Lancet . 1982;  2 939-940
  PubMedGoogle Scholar
• 39 Luscher T F, Noll G, Sturmer T. Calcium gluconate in severe verapamil intoxication.  N Engl J Med . 1994;  330 718-719
  CrossrefPubMedGoogle Scholar
• 40 Nola G T, Pope S, Harrison D C. Assessment of the synergistic relationship between serum calcium and digitalis.  Am Heart J . 1970;  79 499-507
  CrossrefPubMedGoogle Scholar
• 41 Yagami T. Differential coupling of glucagon and beta-adrenergic receptors with the small and large forms of the stimulatory G protein.  Mol Pharmacol . 1995;  48 849-854
  PubMedGoogle Scholar
• 42 Glick G, Parmley W, Weschler A. Glucagon: its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta receptor blockade with propanolol.  Circ Res . 1968;  22 789-799
  PubMedGoogle Scholar
• 43 Parmley W W, Glick G, Sonnenblick E. Cardiovascular effects of glucagons in man.  N Engl J Med . 1968;  279 12-17
  PubMedGoogle Scholar
• 44 Doyon S, Roberts J R. The use of glucagon in a case of calcium channel blocker overdose.  Ann Emerg Med . 1993;  22 1229-1233
  PubMedGoogle Scholar
• 45 Stone C K, Thomas S H, Koury S I. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose.  Acad Emerg Med . 1996;  3 120-125
  PubMedGoogle Scholar
• 46 Walter F G, Frye G, Mullen J T. Amelioration of nifedipine poisoning associated with glucagon therapy.  Ann Emerg Med . 1993;  22 1234-1237
  PubMedGoogle Scholar
• 47 Lvoff R, Wilken D. Glucagon in heart failure and in cardiogenic shock: experience of 50 patients.  Circulation . 1972;  45 534-542
  PubMedGoogle Scholar
• 48 Shore E T, Cepin D, Davidson M J. Metoprolol overdose.  Ann Emerg Med . 1981;  10 524-527
  CrossrefPubMedGoogle Scholar
• 49 Chimienti M, Previtali M, Medici A. Acute verapamil poisoning: successful treatment with epinephrine.  Clin Cardiol . 1982;  5 219-222
  PubMedGoogle Scholar
• 50 Lee K C, Cannif P C, Hamel D W. Cardiovascular and renal effects of milrinone in beta adrenoreceptor blocked and non-blocked anesthetized dogs.  Drugs Exp Clin Res . 1991;  18 145-158
  PubMedGoogle Scholar
• 51 Travill C M, Pugh S, Noble M IM. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.  Clin Ther . 1994;  16 783-792
  PubMedGoogle Scholar
• 52 Wolf L R, Spadafora M P, Otten E J. Use of amrinone and glucagon in a case of calcium channel blocker overdose.  Ann Emerg Med . 1993;  22 1225-1228
  PubMedGoogle Scholar
• 53 Kerns W, Schroeder D, Williams C. Insulin improves survival in a canine model of acute beta-blocker toxicity.  Ann Emerg Med . 1997;  29 748-757
  PubMedGoogle Scholar
• 54 Kline J A, Leonova E, Raymond R M. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine.  Crit Care Med . 1995;  23 1251-1263
  PubMedGoogle Scholar
• 55 Kline J A, Tomaszewski C A, Schroeder J D, Raymond R M. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.  J Pharm Exp Ther . 1993;  267 744-750
  PubMedGoogle Scholar
• 56 Yuan T H, Kerns W P, Tomaszewski, et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.  J Toxicol Clin Toxicol . 1999;  37 463-474
  CrossrefPubMedGoogle Scholar
• 57 Melanson P, Shih R D, DeRoos F. Intra-aortic balloon counterpulsation in calcium channel blocker overdose.  Vet Hum Toxicol . 1993;  35 345
  PubMedGoogle Scholar
• 58 Mcvey F K, Corke C F. Extracorporeal circulation in the management of massive beta blocker overdose.  Anesthesia . 1991;  46 744-746
  PubMedGoogle Scholar
• 59 Hendren W G, Schieber R S, Garrettson L K. Extracorporeal bypass for the treatment of verapamil poisoning.  Ann Emerg Med . 1989;  18 984-987
  PubMedGoogle Scholar